At a glance
This program funds research on new screening methods and treatments for disorders already in newborn screening programs, as well as serious genetic conditions that could be added soon. It is open to a wide range of applicants, including nonprofits, universities, governments, businesses, and foreign organizations, and clinical trials are optional. There is no cost sharing requirement, and application budgets are not limited, though the project period can be no longer than 5 years. The number of awards is not set and depends on NIH appropriations and the quality of applications.
What it funds
Official description from grants.gov
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may be possible in the near future.Having an accurate screening test, as well as demonstrating the benefits of early intervention or treatment, are important criteria for including a condition on a newborn screening panel. This FOA defines a "high priority" condition as one where screening is not currently recommended, but infants with the condition would significantly benefit from early identification and treatment.
Who can apply
- City or township governments
- County governments
- For-profit organizations other than small businesses
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Others
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Small businesses
- Special district governments
- State governments